The events of early October, 2007 may herald a new age of respect for intellectual property (IP) rights. The first trial on peer to peer
The concept is simple, a recent Toronto Star article explains: `By the end of 2009, if all goes according to plan, paper cheques won’t
The United States’ liberal approach to extending patent protection is best illustrated by the court in the Diamond v. Diehr case, where it states “anything
In an attempt to control the HIV/AIDS epidemic in Thailand, the Thai government decided to bypass the patents on anti-retroviral drugs (ARVs) by issuing compulsory
A Swiss pharmaceutical company, Novartis, sought to have the January 2006 decision to reject its patent application for the cancer drug imatinib mesylate (Gleevec) reversed
In May of 2007 scientists at J. Craig Venter Institute filed a U.S. patent application on the world’s first synthetic living organism (U.S. Patent application
